在产后早期的情绪症状的食补充剂:一个双盲随机的安慰剂受控试验
Jeffrey H Meyer1,2, ZhaoHui Wang1,2, Apitharani Santhirakumar1,2
1Brain Health Imaging Centre, Azrieli Centre for Neuro-Radiochemistry, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), 250 College Street, Toronto, M5T 1R8, Canada.
EClinicalMedicine
|May 30, 2024
概括
食补充剂对产后妇女的情绪诱导没有显著影响,但适度减少了产后忧郁症 (PPB). 这一发现表明,对管理PPB症状有潜在的益处.
科学领域:
- 营养精神病学 营养精神病学
- 妇女健康 妇女健康
- 围产期心理健康 围产期心理健康
背景情况:
- 产后忧郁症 (PPB) 影响许多女性,增加产后抑郁症的风险.
- 增加的单胺氧化酶A水平与PPB有关.
- 这项研究研究了一种针对这些影响的食补充剂.
研究的目的:
- 评估一种食补充剂在减少产后忧郁症严重性的有效性.
- 评估补充剂对产后妇女情绪诱导程序的影响.
主要方法:
- 进行了一项随机,双盲,安慰剂控制的试验.
- 参与者接受了补充剂 (蓝汁/提取物,二,氨酸) 或安慰剂.
- 产后忧郁症和情绪诱导在产后第5天被评估.
主要成果:
- 补充剂没有显著影响情绪诱导的主要结果.
- 然而,补充剂组的产后忧郁症得分 (Stein Maternity Blues) 略有下降.
- 在补充剂和安慰剂组之间,不良事件是可比的.
结论:
- 测试的食补充剂在初级情绪诱导结果中没有显示出有效性.
- 观察到对产后忧郁症严重性的中度有益影响.
- 进一步的研究可能会探索针对PPB的食干预措施.
更多相关视频
06:39Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
Published on: June 13, 2021
3.0K
08:42Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression
Published on: May 19, 2015
10.5K
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
220
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
220
The Placebo Effect
6.1K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.1K
